New research suggests a simple clinical interview may be a reliable indicator of dementia and Alzheimer’s disease risk. A study by Florida State University College of Medicine researchers found that a two- to three-hour interview, involving trained interviewers asking memory-testing questions and rating responses on a 1-to-5 scale reliably predicted risk for development of Alzheimer’s… Continue reading Early Detection for Alzheimer’s
Research concluded last year indicates that the compound gossypetin found in hibiscus tea may prevent Alzheimer’s disease. Gossypetin is a flavonoid, one of a group of compounds that give plants their flavors and colors. Researchers conducting the study, funded by the pharmaceutical company NovaMetaPharma Co., found that the compound effectively reversed dementia in mice when… Continue reading Combatting Alzheimer’s with Hibiscus Tea
The results of a recently concluded drug trial may offer hope for Alzheimer’s patients. The drug lecanemab appeared to slow cognitive decline by 27 percent in trial participants (early-stage Alzheimer’s patients), compared to a group that received a placebo. That is considered a significant impact and could potentially be groundbreaking, leading to further drug development. … Continue reading New Drug for Alzheimer’s Patients
Access healing everywhere from your device
We empower healers, doctors and alternative wellness practitioners to reach the world, directly from their device!
